Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).

Author: BakshiRahul P, ColemanJenell S, FuchsEdward J, HendrixCraig W, MarzinkeMark A, RobinsonJennifer A, RohanLisa C, SpiegelHans M L

Paper Details 
Original Abstract of the Article :
OBJECTIVE: Although preexposure prophylaxis with oral tenofovir (TFV) disoproxil fumarate/emtricitabine reduces HIV acquisition rates, poor adherence to and acceptability of daily vaginal gels have led to development of vaginal film formulations to improve adherence and, potentially, to enable episo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/29135651

データ提供:米国国立医学図書館(NLM)

Tenofovir Vaginal Film: A New Frontier in HIV Prevention

This research compares the pharmacokinetic and pharmacodynamic profiles of a new tenofovir vaginal film formulation to a previously studied tenofovir gel. It explores the potential of this new formulation to improve adherence and effectiveness in preventing HIV transmission. The study uses a crossover design, allowing researchers to directly compare the two formulations in a controlled setting.

Tenofovir Film: A Promising Alternative for HIV Prevention

The study reveals that tenofovir film demonstrates consistently higher concentrations of tenofovir in plasma and cervicovaginal fluid compared to the gel formulation. It highlights the potential of tenofovir film as a promising alternative to existing tenofovir formulations, offering improved bioavailability and potentially enhanced effectiveness for HIV prevention. This research is a significant step forward in the ongoing quest for safe and effective HIV prevention strategies.

HIV Prevention: Navigating the Desert of Risk

This research offers a new path in the vast desert of HIV prevention, demonstrating the potential of tenofovir film as a promising alternative to existing formulations. It encourages us to continue exploring new and innovative approaches to HIV prevention, striving to create a future where everyone has access to effective and user-friendly strategies for protecting themselves from this devastating virus.

Dr.Camel's Conclusion

This research guides us through the complex landscape of HIV prevention, unveiling the potential of tenofovir film as a promising new tool in the fight against this global health challenge. It encourages us to continue exploring innovative approaches to HIV prevention, paving the way for a future where everyone can navigate the desert of risk with greater protection and hope.

Date :
  1. Date Completed 2018-12-11
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

29135651

DOI: Digital Object Identifier

NIHMS917323

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.